Dr. Badley received his M.D. degree from Dalhousie University in Halifax, Nova Scotia in 1990. He did residency and Clinician Investigator Training in Infectious Diseases at Mayo Clinic, Rochester Minnesota, graduating in 1997.
Dr. Badley joined the staff of Ottawa Hospital in Ottawa, Ontario, Canada in 1997. In 2002, Dr. Badley returned to the Mayo Clinic as a consultant in Infectious Diseases and moved his successful research laboratory to Mayo Clinic. Dr. Badley currently is Professor of Medicine in the Division of Infectious Diseases. His research has led to >120 peer reviewed publications, he has edited or co-edited 3 books, has written numerous book chapters. His research program has been continuously federally funded since 1997, and he has served on numerous national and international scientific committees, including membership on the prestigious NIH Directors Recombinant DNA advisory committee. Dr. Badley has received numerous awards including the Dr. J. Geraci award for excellence in Infectious, the ICAAC / ASM Young Investigator Award, advancement to membership in the American Society of Clinical Investigation (ASCI), Fellowship in the American College of Physicians, and the Infectious Diseases Society of America.
Dr Badley’s Research focus concerns the regulation of cell death and cell survival during Infectious Diseases, notable HIV, and how understanding these processes can lead to novel therapeutic strategies to reduce morbidity and mortality. Dr Badley currently holds 2 R01 awards, has published over 100 peer reviewed papers, numerous book chapters, and holds or has filed several patents related to his work. Dr Badley has held numerous leadership positions within Mayo clinic, including being the past Associate Dean of Research Resources. Currently Dr Badley is co-PI and director of drug discovery for the Mayo Center for Clinical and Translational Sciences (CCaTS), and is the Director of the Office of Invention and Translation to Practice.